AZD8529   Click here for help

GtoPdb Ligand ID: 7678

Synonyms: AZD 8529 | AZD-8529
Compound class: Synthetic organic
Comment: AZD8529 is a metabotropic glutamate receptor 2 (mGluR2) positive allosteric modulator. Since the original schizophrenia indication is not being pursued it is offered for clinical and preclinical research to explore novel biology with a view to repurposing (it was also in the 2012 NCATS set). Discussed as Case Study (1) in the AZ 2014 review paper [3].
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 5
Hydrogen bond donors 1
Rotatable bonds 7
Topological polar surface area 83.73
Molecular weight 487.18
XLogP 3.87
No. Lipinski's rules broken 0
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES Cc1cc(cc2c1C(=O)N(C2)Cc1ccc(cc1)OC(F)(F)F)c1onc(n1)CN1CCNCC1
Isomeric SMILES Cc1cc(cc2c1C(=O)N(C2)Cc1ccc(cc1)OC(F)(F)F)c1onc(n1)CN1CCNCC1
InChI InChI=1S/C24H24F3N5O3/c1-15-10-17(22-29-20(30-35-22)14-31-8-6-28-7-9-31)11-18-13-32(23(33)21(15)18)12-16-2-4-19(5-3-16)34-24(25,26)27/h2-5,10-11,28H,6-9,12-14H2,1H3
InChI Key IPCYZQQFECEHLI-UHFFFAOYSA-N
References
1. AstraZeneca. 
AZD8529-Open Innovation.
Accessed on 10/09/2014. Modified on 10/09/2014. astrazeneca.com, http://openinnovation.astrazeneca.com/what-we-offer/compound/azd8529/
2. Clayton J etal. (2008)
Oxadiazole Derivatives and Their Use as Metabotropic Glutamate Receptor Potentiators.
Patent number: US20080306077. Assignee: AstraZeneca. Priority date: 04/06/2007. Publication date: 11/12/2008.
3. Cook D, Brown D, Alexander R, March R, Morgan P, Satterthwaite G, Pangalos MN. (2014)
Lessons learned from the fate of AstraZeneca's drug pipeline: a five-dimensional framework.
Nat Rev Drug Discov, 13 (6): 419-31. [PMID:24833294]